Literature DB >> 15084291

Atypical PKC phosphorylates PAR-1 kinases to regulate localization and activity.

Jonathan B Hurov1, Janis L Watkins, Helen Piwnica-Worms.   

Abstract

The establishment and maintenance of cellular polarity are essential biological processes that must be maintained throughout the lifetime of eukaryotic organisms. The Par-1 protein kinases are key polarity determinants that have been conserved throughout evolution. Par-1 directs anterior-posterior asymmetry in the one-cell C. elegans embryo and the Drosophila oocyte. In mammalian cells, Par-1 may regulate epithelial cell polarity. Relevant substrates of Par-1 in these pathways are just being identified, but it is not yet known how Par-1 itself is regulated. Here, we demonstrate that human Par-1b (hPar-1b) interacts with and is negatively regulated by atypical PKC. hPar-1b is phosphorylated by aPKC on threonine 595, a residue conserved in Par-1 orthologs in mammals, worms, and flies. The equivalent site in hPar-1a, T564, is phosphorylated in vivo and by aPKC in vitro. Importantly, phosphorylation of hPar-1b on T595 negatively regulates the kinase activity and plasma membrane localization of hPar-1b in vivo. This study establishes a novel functional link between two central determinants of cellular polarity, aPKC and Par-1, and suggests a model by which aPKC may regulate Par-1 in polarized cells.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15084291     DOI: 10.1016/j.cub.2004.04.007

Source DB:  PubMed          Journal:  Curr Biol        ISSN: 0960-9822            Impact factor:   10.834


  126 in total

1.  Polarity-regulating kinase partitioning-defective 1b (PAR1b) phosphorylates guanine nucleotide exchange factor H1 (GEF-H1) to regulate RhoA-dependent actin cytoskeletal reorganization.

Authors:  Yukie Yamahashi; Yasuhiro Saito; Naoko Murata-Kamiya; Masanori Hatakeyama
Journal:  J Biol Chem       Date:  2011-11-09       Impact factor: 5.157

2.  Symmetry breaking and polarization of the C. elegans zygote by the polarity protein PAR-2.

Authors:  Seth Zonies; Fumio Motegi; Yingsong Hao; Geraldine Seydoux
Journal:  Development       Date:  2010-04-14       Impact factor: 6.868

Review 3.  Microtubule affinity-regulating kinases are potential druggable targets for Alzheimer's disease.

Authors:  Narendran Annadurai; Khushboo Agrawal; Petr Džubák; Marián Hajdúch; Viswanath Das
Journal:  Cell Mol Life Sci       Date:  2017-06-20       Impact factor: 9.261

4.  PAK5 kinase is an inhibitor of MARK/Par-1, which leads to stable microtubules and dynamic actin.

Authors:  Dorthe Matenia; Bettina Griesshaber; Xiao-yu Li; Anja Thiessen; Cindy Johne; Jian Jiao; Eckhard Mandelkow; Eva-Maria Mandelkow
Journal:  Mol Biol Cell       Date:  2005-07-12       Impact factor: 4.138

5.  Stabilization of cell polarity by the C. elegans RING protein PAR-2.

Authors:  Yingsong Hao; Lynn Boyd; Geraldine Seydoux
Journal:  Dev Cell       Date:  2006-02       Impact factor: 12.270

Review 6.  PARtitioning numb.

Authors:  James E Casanova
Journal:  EMBO Rep       Date:  2007-03       Impact factor: 8.807

7.  aPKC-mediated phosphorylation regulates asymmetric membrane localization of the cell fate determinant Numb.

Authors:  Christian A Smith; Kimberly M Lau; Zohra Rahmani; Sascha E Dho; Greg Brothers; Ye Min She; Donna M Berry; Eric Bonneil; Pierre Thibault; François Schweisguth; Roland Le Borgne; C Jane McGlade
Journal:  EMBO J       Date:  2007-01-04       Impact factor: 11.598

Review 8.  The PAR proteins: fundamental players in animal cell polarization.

Authors:  Bob Goldstein; Ian G Macara
Journal:  Dev Cell       Date:  2007-11       Impact factor: 12.270

9.  PAR-3 and PAR-1 inhibit LET-99 localization to generate a cortical band important for spindle positioning in Caenorhabditis elegans embryos.

Authors:  Jui-Ching Wu; Lesilee S Rose
Journal:  Mol Biol Cell       Date:  2007-08-29       Impact factor: 4.138

10.  PAR1 specifies ciliated cells in vertebrate ectoderm downstream of aPKC.

Authors:  Olga Ossipova; Jacqui Tabler; Jeremy B A Green; Sergei Y Sokol
Journal:  Development       Date:  2007-12       Impact factor: 6.868

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.